ICH Q3D Elemental Impurities: List of Elements and PDEs
The complete ICH Q3D elemental impurities list: the 24 elements in Classes 1, 2A, 2B and 3 with oral, parenteral and inhalation PDEs. How to run the risk...
Read the article →GXP ACADEMY · ICH GUIDELINES
Practical analysis of the ICH Q, E, M and S families: pharmaceutical development, quality and risk, impurities, stability, CTD/eCTD dossiers, clinical trials and lifecycle management. Built to clarify what each guideline requires, how it connects to others and what evidence is needed in practice.
ICH Q · E · M · S
Quality, risk, impurities, regulatory dossiers and clinical trials explained through connections, operational criteria and expected evidence.
The complete ICH Q3D elemental impurities list: the 24 elements in Classes 1, 2A, 2B and 3 with oral, parenteral and inhalation PDEs. How to run the risk...
Read the article →
The ICH Q1 revision consolidates the Q1A-Q1F and Q5C guidelines into a single stability testing guideline, with Step 4 adoption expected in November 2026. Here are the confirmed...
Read the article →
How to build the nitrosamine risk assessment required by EMA and FDA: the three steps of the call for review, the template structure, CPCA limits and the mistakes...
Read the article →
A practical guide to ICH Q1 stability testing: Q1A(R2) storage conditions, batches, significant change and the new unified ICH Q1 expected in 2026. What QA, QC and regulatory...
Read the article →
Apply the ICH E Guidelines correctly: monitoring, TMF, risk management, audit trails and pharmacovigilance. Operational guide for QA/QP.
Read the article →
Operational procedure to prepare a CTD/eCTD compliant with the ICH M Guidelines. For RA, CMC and QA teams.
Read the article →